Complying with the new Medicare policy for fitting and delivery of Therapeutic Shoes
In an effort to ensure that patients with Medicare and diabetes are properly fit with therapeutic footwear and inserts, Medicare on May 20th, 2010 updated its therapeutic shoe policy. The clarification will prevent the practice of some mail order supply companies from simply mailing shoes with custom molded inserts to patients based on a single shoe selecting appointment. The revised clarification of the shoe fitting policy reads as follows:
Appendix C of the DMEPOS Quality Standards published in October 2008 addresses specific requirements for orthoses, prostheses, prosthetic devices, and therapeutic shoes. Those standards include requirements for "an in- person diagnosis-specific functional clinical examination" by the supplier to determine the need for a particular item as well as "face-to-face fitting/delivery" by the supplier. Therefore, in order for therapeutic shoes, inserts, and shoe modifications to be covered, both of the following criteria must be met:
1. Prior to selecting the specific items that will be provided, the supplier must conduct and document an in-person evaluation of the patient; and,
2. At the time of delivery of the items selected, the supplier must conduct and document an in-person visit with the patient to ensure that the shoes/inserts/modifications are properly fit and meet the beneficiary's needs.
In order to meet these criteria, effective for claims with dates of service on or after July 1, 2010, the following documentation requirements must be met:
- The in-person evaluation prior to selecting the items must include at least an examination of the patient's feet with a description of the abnormalities that will need to be accommodated by the shoes/inserts/modifications. For all shoes, it must include taking measurements of the patient's feet. For custom molded shoes (A5501) and inserts (A5513), this visit must also include taking impressions, making casts, or obtaining CAD-CAM images of the patient's feet that will be used in creating positive models of the feet.
- The in-person visit at the time of delivery must include an assessment of the fit of the shoes and inserts with the patient wearing them.
Also, in an effort to ensure that the physician managing the patient's diabetes is aware of the foot conditions being accommodated, a number of pre-payment audits have been recently performed. According to the therapeutic footwear LCD:
The Supplier is the person or entity that actually furnishes the shoe, modification, and/or insert to the beneficiary and that bills Medicare. The supplier may be a podiatrist, pedorthist, orthotist, prosthetist or other qualified individual. The Prescribing Physician may be the supplier. The Certifying Physician may only be the supplier if the certifying physician is practicing in a defined rural area or a defined health professional shortage area.
Therapeutic shoes, inserts and/or modifications to therapeutic shoes are covered if the following criteria are met:
1. The patient has diabetes mellitus (ICD-9 diagnosis codes 249.00-250.93); and
2. The certifying physician has documented in the patient's medical record one or more of the following conditions:
a. Previous amputation of the other foot, or part of either foot, or
b. History of previous foot ulceration of either foot, or
c. History of pre-ulcerative calluses of either foot, or
d. Peripheral neuropathy with evidence of callus formation of either foot, or
e. Foot deformity of either foot, or
f. Poor circulation in either foot; and
3. The certifying physician has certified that indications (1) and (2) are met and that he/she is treating the patient under a comprehensive plan of care for his/her diabetes and that the patient needs diabetic shoes.
If criteria 1, 2 or 3 are not met, the therapeutic shoes, inserts and/or modifications to therapeutic shoes will be denied as noncovered. When codes are billed without a KX modifier (see Documentation Requirements section in the accompanying Local Coverage Determination), they will be denied as noncovered.
In order to meet criterion 2, the certifying physician must either:
i. Personally document one or more of criteria a - f in the medical record prior to signing the certification statement; or
ii. Obtain, initial, date (prior to signing the certification statement), and indicate agreement with information from the medical records of a podiatrist, other M.D or D.O., physician assistant, nurse practitioner, or clinical nurse specialist that documents one of more of criteria a - f.
Note: The certification statement is not sufficient to meet the requirement for documentation in the medical record.
The best way for podiatrists to both comply with the supplier requirement that the certifying physician has documented the qualifying conditions is to send a copy of the Comprehensive Diabetic Foot Evaluation foot and request that a signed copy be sent back. Podiatrists should not dispense shoes and inserts unless they have both a signed copy of the required "Document of Therapeutic Necessity" as well as a signed copy of the certifying physician's chart notes indicating documentation of the qualifying risk factors.
SafeStep has available at www.safestep.net additional information about the Medicare therapeutic shoe program, required documentation as well as how to perform the Comprehensive Diabetic Foot Exam.
Arizona AFO, Inc. is the home of the original, patented Arizona AFO®. Located in Mesa, AZ, we are the exclusive central fabrication facility for all Arizona AFO, Inc. products. Our extensive product line can meet the needs of a variety of patients. These products are all custom made utilizing the finest leathers and materials. For more information please visit our website at www.arizonaafo.com or call toll free 1-877-780-8382.
BioMedix Vascular Solutions, Inc. provides the only integrated suite of hardware, software and online services designed to cost-effectively detect Peripheral Arterial Disease (P.A.D.) and Chronic Venous Insufficiency (CVI). Vascular specialists, primary care and podiatric physicians, hospitals and health systems use our products to identify these patients. Our devices and Health Information Technology (HIT) software reduce mistakes, provide data for sound analysis, build practice revenue and streamline reimbursement while providing a platform that supports the continuum of care and increased quality outcomes.
Amerx Health Care Corporation is the manufacturer of Amerigel Skin and Wound Care products. Exclusive to the Amerigel® product line, the ingredient Oakin is proven to heal wounds and skin conditions and improve patient outcomes. This unique formulation and the company's commitment to quality, consistency and service has earned Amerigel® Wound Dressing the #1 rating for the past 6 years in the podiatric profession. For more information on the Amerigel products, please visit our website: www.amerigel.com or call toll free: 1-800-448-9599.
Bako Pathology Services www.bakopathology.com is a physician-owned provider of a wide array of pathology services ranging from histopathologic examination of bone, soft tissue, and skin/nail unit, to microbiology and epidermal nerve fiber density testing. We pride ourselves on providing the best available customer service, concise reports with therapeutic options, photomicrographic imaging, compliant and patient-friendly billing policies, internet-based report access, and a client/patient comes-first business model.
At Bako Pathology Services, we're not just providing a premium pathology service; we're dedicated to the advancement of this great profession through Education, Research, and Financial Support.
"SafeStep Does DME" and is the podiatrist's complete source for diabetic shoes, prefabricated and custom AFO's and ready-made inserts. Featuring footwear from Aetrex, OrthoFeet, New Balance, Pedors, Crocs, Brooks, Hush Puppies and others. AFO's from Ossur, Aircast, Swede-O, DJO, Darco and more. SafeStep is the exclusive podiatric distributor of the Arizona AFO. SafeStep exclusively offers free electronic billing to Medicare and private insurance companies.
Click here to access marketing material related to Mrs. Smith.
Since 2002, Officite has been a leading national provider of customized Web sites and marketing solutions for dental and medical practices. More than 3,500 doctors have grown their practices with our state-of-the-art online capabilities and marketing materials. Our staff of web developers, writers, designers and programmers stays on the cutting edge of technology and marketing to ensure that every Officite Web site produces results. Let Officite be your partner for online marketing success.